FIELD: biotechnology.
SUBSTANCE: method consists of processing the tested samples with 3-propiolactone final concentration 0.1% in sample within 8-10 hours at +37°С.
EFFECT: higher biologic safety of manipulations with infected or suspected to be infectious material in performing serum tests by staff; reduction of material inactivation time 2-4 hr.
2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINATION OF FOODSTUFF CONTAMINATION WITH PATHOGENIC BIOLOGICAL AGENTS IN EXTREME SITUATIONS | 2006 |
|
RU2350656C2 |
| METHOD FOR Yersinia pestis Yersinia pseudotuberculosis STRAIN IDENTIFICATION | 2010 |
|
RU2422535C1 |
| METHOD FOR PROGNOSTICATION OF CLINICAL EFFECTIVENESS OF ANTIBACTERIAL, VACCINE PREPARATIONS, AGENTS FOR PASSIVE ANTITOXIC IMMUNOTHERAPY ON MODEL OF INFECTIOUS-TOXIC PLAGUE FORM IN MICE | 2005 |
|
RU2303821C2 |
| METHOD FOR PREPARING ASSOCIATED VACCINE AGINST SALMONELLOSIS AND ENTEROCOCCAL INFECTION IN NUTRIAS | 2005 |
|
RU2292914C1 |
| METHOD FOR PREPARING MIXED VACCINE AGAINST COLI-BACTERIOSIS, SALMONELLOSIS AND STREPTOCOCCOSIS IN NUTRIA | 2006 |
|
RU2301077C1 |
| METHOD FOR MODELING SYMBIOSIS OF PLAGUE PATHOGEN CELLS WITH SAPROPHYTE MYXOCOCCUS XANTHUS | 2001 |
|
RU2203955C1 |
| SET FOR DIFFERENTIAL DIAGNOSIS OF OMSK HEMORRHAGIC FEVER AND TICK-BORNE ENCEPHALITIS | 1993 |
|
RU2061959C1 |
| STRAIN OF CULTIVATED HYBRID CELLS OF ANIMAL MUS MUSCULUS L CCHFV Vd-2-PRODUCER OF MONOCLONAL ANTIBODY 1E2/E5 TO VIRUS OF CRIMEAN-CONGO HAEMORRHAGIC FEVER | 2013 |
|
RU2528868C1 |
| METHOD FOR PREPARING ASSOCIATED VACCINE AGINST SALMONELLOSIS AND COLIBACTERIOSIS IN NUTRIAS | 2005 |
|
RU2292915C1 |
| HYBRID CELL STRAIN OF MUS MUSCULUS 13F8 ANIMALS - PRODUCER OF MONOCLONAL ANTIBODIES SPECIFIC TO CAPSULAR F1 ANTIGEN YERSINIA PESTIS | 2011 |
|
RU2460788C1 |
